Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
27,225,781
-
Share change
-
+5,993,913
-
Total reported value
-
$12,851,002
-
Price per share
-
$0.47
-
Number of holders
-
68
-
Value change
-
+$1,269,827
-
Number of buys
-
39
-
Number of sells
-
16
Institutional Holders of VBI VACCINES INC CDA - COM NEW (VBIV) as of Q3 2019
As of 30 Sep 2019,
VBI VACCINES INC CDA - COM NEW (VBIV) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,225,781 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, GENERAL AMERICAN INVESTORS CO INC, 683 Capital Management, LLC, Blackstone Group Inc, Cambridge Investment Research Advisors, Inc., Alyeska Investment Group, L.P., Harel Insurance Investments & Financial Services Ltd., STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
68
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.